Treatment of cystic fibrosis in low-income countries

Lancet Respir Med. 2016 Feb;4(2):91-2. doi: 10.1016/S2213-2600(15)00507-X.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use*
  • Carrier State / drug therapy*
  • Chest Wall Oscillation / economics
  • Chest Wall Oscillation / methods*
  • Cystic Fibrosis / economics
  • Cystic Fibrosis / therapy*
  • Delivery of Health Care / economics
  • Delivery of Health Care / organization & administration
  • Developing Countries*
  • Enzyme Replacement Therapy / economics
  • Enzyme Replacement Therapy / methods*
  • Humans
  • Patient Compliance
  • Pseudomonas Infections / drug therapy*
  • Respiratory Therapy / economics
  • Respiratory Therapy / methods
  • Vitamin A / therapeutic use
  • Vitamin D / therapeutic use
  • Vitamin E / therapeutic use
  • Vitamins / economics
  • Vitamins / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Vitamins
  • Vitamin A
  • Vitamin D
  • Vitamin E